iollo

iollo is a health technology company that specializes in at-home metabolomics testing, providing users with personalized health insights based on the analysis of over 500 biomarkers in their blood. The company, founded in 2022 with its headquarters in San Francisco, leverages generative artificial intelligence to create personalized action plans for diet, behavior, and potentially therapeutic interventions. iollo's platform is primarily available as a web application, and its services are designed to help individuals understand and improve their metabolic health, making it particularly useful for those interested in personalized health and wellness.

Key Features of iollo:
- Metabolomics Testing: Analyzes over 500 biomarkers in blood samples to provide comprehensive health insights.
- Personalized Action Plans: Utilizes AI algorithms to generate customized recommendations for diet and lifestyle based on individual test results.
- At-Home Testing Kit: Users receive a microsampling device to collect blood samples comfortably at home.
- Regular Monitoring: Encourages ongoing testing to track health changes and adjust recommendations as needed.
- Integration with Wearables: Supports data integration from third-party health apps and wearables to enhance personalized insights.

iollo uses generative AI to analyze complex biological data and generate personalized health recommendations. The specific details on the AI models used, such as LLM or foundation model specifics, are not publicly disclosed.

iollo is available as a web application, with no mention of availability as a mobile app, API, or SDK. The company was launched in 2022, and its pricing structure includes various subscription tiers, starting from $23.00 per month when billed annually. These tiers differ based on the frequency of tests and the level of insight provided.

iollo is ideal for individuals who are proactive about their health, particularly those with specific health conditions like PCOS, or those interested in longevity and wellness optimization. It is also suitable for those who prefer the convenience of at-home testing and are comfortable using digital platforms to manage their health.

There is no indication that iollo's software or any components of its platform are open source. The technology and algorithms used for data analysis and recommendation generation are proprietary to iollo.